Tirzepatide (Mounjaro) - Update

A message from NHS Surrey

Tirzepatide (Mounjaro®) is a new treatment option for managing obesity.

If you are eligible for tirzepatide on the NHS, you will be contacted by your GP surgery.  Please do not contact them.

Some people living with obesity may be eligible to access tirzepatide for weight loss purposes in community settings as outlined in NICE guidelines.

The treatment is prioritised for those with the greatest clinical need. The number of people eligible will be small initially, including those people living with obesity or in poor health with multiple obesity related conditions, as they would benefit most from the treatment.

For more information, including a link to the NICE guidelines, please visit the Surrey Heartlands website.

Published on 23 June 2025